Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Nlrp3 Inflammasome: Significance and Potential Therapeutic Targets to Advance Solid Organ Transplantation Publisher Pubmed



Davoodi Karsalari P1 ; Asna Ashari K1, 2, 3 ; Rezaei N1, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Network of Immunity in Infection, Malignancy and Autoimmunity, Universal Scientific Education and Research Network (USERN), Tehran, Iran
  2. 2. Department of Pediatrics, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Division of Immunology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, United States
  4. 4. Research Center for Immunodeficiencies, Children’s Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Expert Opinion on Therapeutic Targets Published:2025


Abstract

Introduction: NOD-like receptor (NLR) family pyrin domain-containing 3 (NLRP3) inflammasome, integral to innate immunity, has become a pivotal figure in the inflammatory cascade. Areas covered: This article provides an overview of the NLRP3 inflammasome, reviewing its complicated structure, as well as the diverse signals that trigger its assembly. Furthermore, we explored the intricate relationship between the NLRP3 inflammasome and acute and chronic rejection in solid organ transplantation. Solid organ transplantation stands as a crucial medical intervention, yet its efficacy is challenged by immune-mediated complications, including acute rejection, ischemia-reperfusion injury, and chronic allograft rejection. We also investigated the encouraging potential of immunosuppressive therapies targeting NLRP3 signaling to alleviate inflammatory responses linked to transplantation. Expert opinion: In recent years, the NLRP3 inflammasome has garnered considerable attention owing to its critical functions spanning diverse fields. This study highlights the critical function of the NLRP3 inflammasome and presents insights, offering fresh perspectives on how its modulation might help to improve the outcomes among patients who undergo solid organ transplantations. © 2025 Informa UK Limited, trading as Taylor & Francis Group.
Other Related Docs
19. The Role of Inflammasome Complex in Ischemia-Reperfusion Injury, Journal of Cellular Biochemistry (2023)
21. Infection and Immunity, Clinical Immunology (2022)
22. Regulatory Effects of Trimetazidine in Cardiac Ischemia/Reperfusion Injury, Naunyn-Schmiedeberg's Archives of Pharmacology (2023)
34. Caspase-1 Inhibition Prevents Glial Inflammasome Activation and Pyroptosis in Models of Multiple Sclerosis, Proceedings of the National Academy of Sciences of the United States of America (2018)
39. Tlr/Mtor Inflammatory Signaling Pathway: Novel Insight for the Treatment of Schizophrenia, Canadian Journal of Physiology and Pharmacology (2023)
40. Inflammasome: Its Role in Traumatic Brain and Spinal Cord Injury, Journal of Cellular Physiology (2018)
43. An Overview of High-Mobility Group Box 1, a Potent Pro-Inflammatory Cytokine in Asthma, Journal of Basic and Clinical Physiology and Pharmacology (2020)
45. Mitochondria Signaling Pathways in Allergic Asthma, Journal of Investigative Medicine (2022)